CoChat

Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one‐step and two‐step methods

Meltzer, SJ, Snyder, J, Penrod, JR, Nudi, M, Morin, L · 2010 · BJOG: An International Journal of Obstetrics & Gynaecology
Cited by 121

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Please cite this paper as: Meltzer S, Snyder J, Penrod J, Nudi M, Morin L. Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one‐step and two‐step methods. BJOG 2010;117:407–415. Objective To conduct a cost minimisation analysis of three methods of gestational diabetes mellitus (GDM) screening and diagnosis. Design Prospective randomised controlled trial. Setting University teaching hospital. Population Pregnant women (n = 1594) presenting for GDM screening. Methods Women presenting for GDM screening, who consented to participate, were randomised to GR1 [1‐hour, 50‐g glucose screen (GS) ± 3‐hour, 100‐g oral glucose tolerance test (OGTT)], GR2 (50‐g GS ± 2‐hour, 75‐g OGTT) or GR3 (2‐hour, 75‐g OGTT). Demographics, health and time/travel cost information were assessed for each glucose testing visit. Main outcome measures Costs (direct and indirect) and prevalence of GDM diagnosis. Results The direct sampling costs of the glucose tests per woman were as follows: GS, CAN$12.57; 75‐g OGTT, $36.10; 100‐g OGTT, CAN$48.13. Among women in the two‐step method groups diagnosed with GDM, 39% of the GR1 and 61% of the GR2 groups were diagnosed at the first step by GS ≥ 10.3 mmol/l, according to the Canadian Diabetes Association recommendations, contributing to a lower total cost in these groups. The total costs per woman screened were as follows: GR1, CAN$91.61; GR2, CAN$89.03; GR3, CAN$108.38. The GDM prevalence was similar (3.7%, 3.7% and 3.6%, respectively). The higher costs of GR3 were related to more blood draws and the time required for all women to undergo the 2‐hour OGTT. Conclusions Careful consideration should be given to an internationally recommended method of universal screening for GDM which minimises the burden and cost for individual women and the healthcare system, yet provides diagnostic efficacy. The two‐step method (GS ± OGTT) accomplished this better than the one‐step method (75‐g OGTT).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-0528.2009.02475.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 121

Metadata

Authors
Meltzer, S., Snyder, J., Penrod, Jr., Nudi, M., & Morin, L.
Venue
BJOG: An International Journal of Obstetrics & Gynaecology
Publisher
Wiley
Published
2010-01-26
Volume
117
Issue
4
Pages
407-415
ISSN
  • 0306-5456 (ISSN-L)
  • 1470-0328
  • 1471-0528
OpenAlex
W1520818625
Cited by
121
References
5
FWCI
16.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one‐step and two‐step methods. https://app.cochat.ai/papers/10.1111/j.1471-0528.2009.02475.x
The paper
Meltzer, S., Snyder, J., Penrod, Jr., Nudi, M., & Morin, L. (2010). Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one‐step and two‐step methods. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/j.1471-0528.2009.02475.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.